For those that making claims that Leo should have pursued Phase III for B ABSSSI, see the FDA statement below and you will see why IPIX smartly elected to determine the B-OM and B-UP capabilities first.

https://www.fda.gov/NewsEvents/Newsroom/Press...rce=Eloqua